Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2025-12-30 @ 5:58 AM
Study NCT ID:
NCT00887068
Status:
COMPLETED
Last Update Posted:
2020-01-14
First Post:
2009-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04-21
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-20
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-22
First Submit QC Date:
None
Study First Post Date:
2009-04-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-12-19
Results First Submit QC Date:
None
Results First Post Date:
2020-01-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-06
Last Update Post Date:
2020-01-14
Last Update Post Date Type:
ACTUAL